PATENT CLAIM ANALYSIS

Application Number: 15886659
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "468000"]

Abstract:
Opioid controlled release formulation resistant to alcohol extraction of the opioid.

Claim (Index 91):
The dosage form of any of  claims 37  to  90 , wherein the opioid salt is hydromorphone hydrochloride, and comprises:\n 2 mg hydromorphone hydrochloride, \n 4 mg hydromorphone hydrochloride, \n 8 mg hydromorphone hydrochloride, \n 12 mg hydromorphone hydrochloride, \n 16 mg hydromorphone hydrochloride, \n 24 mg hydromorphone hydrochloride, \n 32 mg hydromorphone hydrochloride, \n 48 mg hydromorphone hydrochloride, or \n 64 mg hydromorphone hydrochloride.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13900873', '13333560', '13901218', '14040535', '15245338']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7073162392199371
- 35 USC 102 Novelty (BERT): 0.5517387261642657
- Combined Prediction Score: 0.69175848791437
- Mean Citation Score: 395.594268
- Max Citation Score: 406.89218
- Similarity Product: 290.35490459268925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test